GMED Earnings

GMED reported its earnings on 2026-05-07, showcasing a revenue of 759.85M against an estimate of 728.94M, resulting in a 4.24% surprise. The EPS was 1.12, surpassing the expected 0.92 by 21.74%. The stock experienced a -8.37% price change on the earnings day and a 0% change over the next five days, reflecting market reactions to the results.

Following GMED's earnings announcement on 2026-05-07, the stock price moved by -8.37% on the day of the release. Over the subsequent five days, it saw a 0% change. Historically, GMED's stock price tends to shift by an average of 1.63% in the 10 days leading up to earnings and 4.17% in the 10 days following, providing insight into potential market.

For 2026/Q2, analysts estimate GMED's annual revenue to reach 776.43M, while the EPS is projected at 1.00. These estimates reflect recent revisions, with revenue estimates unchanged by 0% and EPS estimates unchanged by 0% over the past three months, indicating analyst expectation in the company's performance.

The correlation between GMED's stock price and earnings forecast revisions shows that positive revisions in revenue or EPS often strengthen the stock's fundamentals. Over the past three months, revenue estimates for FY2025 were unchanged by 0%, while EPS estimates moved unchanged by 0%. This trend suggests that price dips could present buying opportunities for investors.

Based on historical trends, GMED's stock price typically moves by 1.63% in the 10 days before its earnings and 4.17% in the 10 days after. For the upcoming 2026/Q2 earnings, analysts expect an EPS of 1.00 and revenue of 776.43M.

The earnings call summary indicates strong financial performance, with a 10% revenue increase and improved operating income and EPS. Despite a slight decrease in gross margin, overall financial health appears robust. The absence of strategic updates or risks discussed suggests no immediate concerns. The Q&A section did not reveal any analyst dissatisfaction. Given these factors, the stock price is likely to experience a positive movement, though not dramatically so, due to the lack of additional catalysts or market cap data.